avkАрхивъ внутренней медициныThe Russian Archives of Internal Medicine2226-67042411-6564“SINAPS” LLC10.20514/2226-6704-2021-11-4-245-254avk-1267Research ArticleОБЗОРНЫЕ СТАТЬИREVIEW ARTICLESАлопеция в структуре клинических проявлений эндокринопатий: патогенетические и диагностические аспектыAlopecia and Clinical Presentation of Endocrinopathies: Pathogenetic and Diagnostic Aspectshttps://orcid.org/0000-0002-9523-5966ПраскурничийЕ. А.PraskurnichiyE. A.

Евгений Аркадьевич Праскурничий

Москва

 Moscow

praskurnichey@mail.ruhttps://orcid.org/0000-0003-2847-8711ГрачеваС. А.GrachevaS. A.

Москва

Moscow

https://orcid.org/0000-0002-5694-5244КуганН. В.KuganN. V.

Москва

Moscow

МасленниковаО. М.MaslennikovaO. M.

Москва

Moscow

Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской ФедерацииРоссияRussian Federal Academy of Continued Medical Education, Healthcare Ministry of RussiaRussian FederationФедеральное государственное бюджетное учреждение «Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр им. А.И. Бурназяна» Федерального медико-биологического агентства Российской ФедерацииРоссияA.I. Burnazyan State Scientific Center of the Russian Federation – Federal Medical Biophysical Center, Federal Medical and Biological Agency of RussiaRussian FederationФедеральное государственное бюджетное учреждение дополнительного профессионального образования «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияCentral State Medical Academy of Presidential AffairsRussian Federation202112082021114245254Copyright © Праскурничий Е.А., Грачева С.А., Куган Н.В., Масленникова О.М., 20212021Праскурничий Е.А., Грачева С.А., Куган Н.В., Масленникова О.М.Praskurnichiy E.A., Gracheva S.A., Kugan N.V., Maslennikova O.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medarhive.ru/jour/article/view/1267

В обзоре рассмотрены ключевые аспекты патогенеза алопеции при патологии эндокринной системы. Продемонстрирована роль целого ряда гормонов, факторов роста, цитокинов и других биологически активных веществ. Показано, что клиническое значение алопеции – весьма распространенного в популяции симптома – далеко не исчерпывается геронтологической проблематикой, и может быть проявлением эндокринопатий. Указанное обстоятельство диктует проведение в целом ряде случаев широкого дифференциально-диагностического поиска, выполнение которого наиболее перспективно при условии реализации мультидисциплинарного подхода с участием эндокринолога, гинеколога, андролога, дерматолога / трихолога и других специалистов.

The review examines the key aspects of the pathogenesis of alopecia in endocrine system pathology. The role of hormones, growth factors, cytokines and other biologically active substances has been demonstrated. Alopecia is a frequent symptom that can be the result of not only gerontological, but also endocrinological problems. Therefore, time-consuming differential diagnosis is often necessary. Diagnosis is more effective if a team of specialists is involved: endocrinologist, gynecologist, andrologist, dermatologist / trichologist, and others.

алопецияэндокринная системаэндокринопатиитрихологиямультидисциплинарный подходalopeciaendocrine systemendocrinopathiestrichologymultidisciplinary approachReferencesTrüeb R.M. The difficult Hair Loss Patient. Guide to Successful Management of Alopecia and Related Conditions. SpringerInternationalPublishing. 2015; 331 p. DOI: 10.1007/978-3-319-19701-Trüeb R.M. The difficult Hair Loss Patient. Guide to Successful Management of Alopecia and Related Conditions. SpringerInternationalPublishing. 2015; 331 p. DOI: 10.1007/978-3-319-19701-Трихология: диагностика, лечение и уход за волосами. Под ред. Эрнандес Е.И. М. Косметика и Медицина. 2016; 412 с. Trichology: diagnosis, treatment and hair care. Ernandes E.I. M., Cosmetics and Medicine. 2016; 412 p. [In Russian].Трихология: диагностика, лечение и уход за волосами. Под ред. Эрнандес Е.И. М. Косметика и Медицина. 2016; 412 с. Trichology: diagnosis, treatment and hair care. Ernandes E.I. M., Cosmetics and Medicine. 2016; 412 p. [In Russian].Batrinos M.L. The endocrinology of baldness. Hormones. 2014; 13(2):197-212. DOI: 10.1007/BF03401334.Batrinos M.L. The endocrinology of baldness. Hormones. 2014; 13(2):197-212. DOI: 10.1007/BF03401334.Hamilton J.B. Effect of castration in adolescent and young adult upon further changes in the proportion of bare and hairy scalp. J ClinEndocrinolMetab. 1960; 20:1309-18. DOI:10.1210/jcem-20-10-1309.Hamilton J.B. Effect of castration in adolescent and young adult upon further changes in the proportion of bare and hairy scalp. J ClinEndocrinolMetab. 1960; 20:1309-18. DOI:10.1210/jcem-20-10-1309.Sinclair R.D. Male pattern androgenetic alopecia BMJ. 1998; 317(7162): 865–869. DOI: 10.1136/bmj.317.7162.865.Sinclair R.D. Male pattern androgenetic alopecia BMJ. 1998; 317(7162): 865–869. DOI: 10.1136/bmj.317.7162.865.Herskovitz I., Tosti A. Female pattern hair loss. Int J EndocrinolMetab. 2013; 11(4):e9860. DOI:10.5812/ijem.9860.Herskovitz I., Tosti A. Female pattern hair loss. Int J EndocrinolMetab. 2013; 11(4):e9860. DOI:10.5812/ijem.9860.Glaser R.L., Dimitrakakis C., Messenger A.G. Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study. Br J Dermatol. 2012; 166(2):274–278. DOI: 10.1111/j.1365-2133.2011.10655.x.Glaser R.L., Dimitrakakis C., Messenger A.G. Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study. Br J Dermatol. 2012; 166(2):274–278. DOI: 10.1111/j.1365-2133.2011.10655.xGrymowicz M., Rudnicka E., Podfigurna A., et al. Hormonal Effects on Hair Follicles Int J Mol Sci. 2020; 21(15): 5342. DOI: 10.3390/ijms21155342.Grymowicz M., Rudnicka E., Podfigurna A., et al. Hormonal Effects on Hair Follicles Int J Mol Sci. 2020; 21(15): 5342. DOI: 10.3390/ijms21155342.Thornton M.J. The biological actions of estrogens on skin. Exp Dermatol.2002; 11(6):487-502. DOI: 10.1034/j.1600-0625.2002.110601.x.Thornton M.J. The biological actions of estrogens on skin. Exp Dermatol.2002; 11(6):487-502. DOI: 10.1034/j.1600-0625.2002.110601.x.Shi-Sheng Zhou Da Li, Yi-Ming Zhou, et al. The skin function: a factor of anti-metabolic syndrome. DietologMetabSyndr. 2012;4(1):15. DOI: 10.1186/1758-5996-4-15.Shi-Sheng Zhou Da Li, Yi-Ming Zhou, et al. The skin function: a factor of anti-metabolic syndrome. DietologMetabSyndr. 2012;4(1):15. DOI: 10.1186/1758-5996-4-15.Gallicchio L., Calhoun C., Helzlsouer K.J. Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Res Treat. 2013; 142(2):435-43. DOI: 10.1007/s10549-013-2744-2.Gallicchio L., Calhoun C., Helzlsouer K.J. Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Res Treat. 2013; 142(2):435-43. DOI: 10.1007/s10549-013-2744-2.Riedel-Baima B., Riedel A. Female pattern may be triggered by oestrogen to androgen ratio. EndocrRegul. 2008; 42(1):13-6.Riedel-Baima B., Riedel A. Female pattern may be triggered by oestrogen to androgen ratio. EndocrRegul. 2008; 42(1):13-6.Langlade C., Gouverneur A., Bosco-Lévy P., et al. Adverse events reported for Mirena levonorgestrel-releasing intrauterine device in France and impact of media coverage. Br J Clin Pharmacol. 2019; 85(9): 2126–2133. DOI: 10.1111/bcp.14027.Langlade C., Gouverneur A., Bosco-Lévy P., et al. Adverse events reported for Mirena levonorgestrel-releasing intrauterine device in France and impact of media coverage. Br J Clin Pharmacol. 2019; 85(9): 2126–2133. DOI: 10.1111/bcp.14027.Fabbriocini G., Cantelli M., Masara A., et al. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018; 4(4): 203–211. DOI: 10.1016/j.ijwd.2018.05.001.Fabbriocini G., Cantelli M., Masara A., et al. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018; 4(4): 203–211. DOI: 10.1016/j.ijwd.2018.05.001.Riux C., Pelissier C., Fechtenbaum J., et al. Randomized, doublemasked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporos Int. 2002;13(3):241-8. DOI: 10.1007/s001980200021.Riux C., Pelissier C., Fechtenbaum J., et al. Randomized, doublemasked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporos Int. 2002;13(3):241-8. DOI: 10.1007/s001980200021.Brough K.R., Torgerson R.R. Hormonal therapy in female pattern hair loss. Int J Women Dermatol. 2017; 3(1):53-57. DOI: 10.1016/j. ijwd.2017.01.001.Brough K.R., Torgerson R.R. Hormonal therapy in female pattern hair loss. Int J Women Dermatol. 2017; 3(1):53-57. DOI: 10.1016/j. ijwd.2017.01.001.Hagenaars S.P., Hill W.D., Harris S.E., et al. Genetic prediction of male pattern baldness. PLOS Genetics. 2017; 13(2):e1006594. DOI:10.1371/journal.pgen.1006594.Hagenaars S.P., Hill W.D., Harris S.E., et al. Genetic prediction of male pattern baldness. PLOS Genetics. 2017; 13(2):e1006594. DOI:10.1371/journal.pgen.1006594.Cassidenti D.L., Paulson R.J., et al. Effectsofsexsteroids on skin 5 alpha-reductaseactivity in vitro. ObstetGynecol. 1991;78(1):103-7.Cassidenti D.L., Paulson R.J., et al. Effectsofsexsteroids on skin 5 alpha-reductaseactivity in vitro. ObstetGynecol. 1991;78(1):103-7.Oettel M., Mukhopadhyay A.K. Progesterone: the forgotten hormone in men? Aging Male. 2004; 7(3):236-57. DOI: 10.1080/13685530400004199.Oettel M., Mukhopadhyay A.K. Progesterone: the forgotten hormone in men? Aging Male. 2004; 7(3):236-57. DOI: 10.1080/13685530400004199.Serafini P., Lobo R.A. Prolactin modulates peripheral androgen metabolism. FertilSteril. 1986; 45(1):41-6. DOI: 10.1016/S0015-0282(16)49094-1.Serafini P., Lobo R.A. Prolactin modulates peripheral androgen metabolism. FertilSteril. 1986; 45(1):41-6. DOI: 10.1016/S0015- 0282(16)49094-1.Tirgar-Tabari S., Sharbatdaran M., Manafi-Akham S., et al. Hyperprolactinemia and hirsutism in patients without polycystic ovary syndrome Int J Trichology. 2016; 8(3):130–134. DOI: 10.4103/0974- 7753.188998.Tirgar-Tabari S., Sharbatdaran M., Manafi-Akham S., et al. Hyperprolactinemia and hirsutism in patients without polycystic ovary syndrome Int J Trichology. 2016; 8(3):130–134. DOI: 10.4103/0974- 7753.188998.Trüeb R.M.Hormones and hair growth. Hautarzt. 2010; 61(6):487-95. DOI: 10.1007/s00105-009-1890-2.Trüeb R.M.Hormones and hair growth. Hautarzt. 2010; 61(6):487-95. DOI: 10.1007/s00105-009-1890-2.Lutz G. Hair loss and hyperprolactinemia in women. Dermatoendocrinol. 2012; 4(1): 65–71. DOI: 10.4161/derm.19472.Lutz G. Hair loss and hyperprolactinemia in women. Dermatoendocrinol. 2012; 4(1): 65–71. DOI: 10.4161/derm.19472.Gaspar E., Nguyen-Thi K.T., Hardenbicker C., et al. Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol. 2011; 131(12):2368-77. DOI: 10.1038/jid.2011.221.Gaspar E., Nguyen-Thi K.T., Hardenbicker C., et al. Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol. 2011; 131(12):2368-77. DOI: 10.1038/jid.2011.221.Paus R., Langan E.A., Vidali S., et al. Neuroendocrinology of the hair follicle: principles and clinical perspectives. Trends in Molecular Medicine. 2014; 20(10):559-70. DOI: 10.1016/j.molmed.2014.06.002.Paus R., Langan E.A., Vidali S., et al. Neuroendocrinology of the hair follicle: principles and clinical perspectives. Trends in Molecular Medicine. 2014; 20(10):559-70. DOI: 10.1016/j.molmed.2014.06.002.Contreras-Jurado C., Lorz C., Garcia-Serrano L., et al. Thyroid hormone signaling controls hair follicle stem cell function. Mol Biol Cell. 2015; 26(7):1263–1272. DOI: 10.1091/mbc.E14-07-1251.Contreras-Jurado C., Lorz C., Garcia-Serrano L., et al. Thyroid hormone signaling controls hair follicle stem cell function. Mol Biol Cell. 2015; 26(7):1263–1272. DOI: 10.1091/mbc.E14-07-1251.Vincent M., Yogiraj K.A. Descriptive study of alopecia patterns and their relation to thyroid dysfunction. Int J Trichology. 2013; 5(1): 57–60. DOI: 10.4103/0974-7753.114701.Vincent M., Yogiraj K.A. Descriptive study of alopecia patterns and their relation to thyroid dysfunction. Int J Trichology. 2013; 5(1): 57–60. DOI: 10.4103/0974-7753.114701.Siah T.W., Muir-Green L., Shapiro J. Female Patttern Hair Loss: A Retrospective Study in a Tertiary Refferal Center. Int. J Trichology. 2016; 8(2):57-61. DOI: 10.4103/0974-7753.188033.Siah T.W., Muir-Green L., Shapiro J. Female Patttern Hair Loss: A Retrospective Study in a Tertiary Refferal Center. Int. J Trichology. 2016; 8(2):57-61. DOI: 10.4103/0974-7753.188033.Jagadish K, Kumar M.S., Kumar T.S., et al. Diffuse scalp hair loss due to levothyroxine overdose. Indian Dermatol Online J. 2015; 6(Suppl 1):S58–S60. DOI: 10.4103/2229-5178.171054.Jagadish K, Kumar M.S., Kumar T.S., et al. Diffuse scalp hair loss due to levothyroxine overdose. Indian Dermatol Online J. 2015; 6(Suppl 1):S58–S60. DOI: 10.4103/2229-5178.171054.Pike J.W., Christakos S. Biology and mechanism of action of the vitamin D hormone. EndocrinolMetabClin North Am. 2017; 46(4):815-843. DOI: 10.1016/j.ecl.2017.07.001.Pike J.W., Christakos S. Biology and mechanism of action of the vitamin D hormone. EndocrinolMetabClin North Am. 2017; 46(4):815-843. DOI: 10.1016/j.ecl.2017.07.001.Yao X, Lawson M.S., Fuhua Xu, et al. Vitamin D receptor expression and potential role of vitamin D on cell proliferation and steroidogenesis in goat ovarian granulosa cells. Theriogenology. 2017; 15(102):162-173. DOI: 10.1016/j.theriogenology.2017.08.002.Yao X, Lawson M.S., Fuhua Xu, et al. Vitamin D receptor expression and potential role of vitamin D on cell proliferation and steroidogenesis in goat ovarian granulosa cells. Theriogenology. 2017; 15(102):162-173. DOI: 10.1016/j.theriogenology.2017.08.002.Hanif F., Ilyas N., Qamar T. Association of vitamin D deficiency with hyperandrogegism in females with polycystic ovarian syndrome. International Journal of Clinical and Biomedical Research. 2018; 4(2):31-34. DOI: 10.5455/ijcbr.2018.42.07.Hanif F., Ilyas N., Qamar T. Association of vitamin D deficiency with hyperandrogegism in females with polycystic ovarian syndrome. International Journal of Clinical and Biomedical Research. 2018; 4(2):31-34. DOI: 10.5455/ijcbr.2018.42.07.Lundqvist J. Vitamin D as a regulator of steroidogenic enzymes. F1000research. 2014; 3:155. DOI: 10.12688/f11000research.4714.1.Lundqvist J. Vitamin D as a regulator of steroidogenic enzymes. F1000research. 2014; 3:155. DOI: 10.12688/f11000research. 4714.1.Bakhshalizadeh S., Amidi F., Alleyassin A., et al. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome. SystBiolReprod Med. 2017; 63(3):150-161. DOI: 10.1080/19396368.2017.1296046.Bakhshalizadeh S., Amidi F., Alleyassin A., et al. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome. SystBiolReprod Med. 2017; 63(3):150-161. DOI: 10.1080/19396368.2017.1296046.Rasheed H., MahgoubD.,HegazyR., et al. Serum ferritin and vitamin D in female pattern hair loss: do they play the role? Skin Pharmacol Physiol. 2013; 26(2):101-7. DOI: 10.1159/000346698.Rasheed H., MahgoubD.,HegazyR., et al. Serum ferritin and vitamin D in female pattern hair loss: do they play the role? Skin Pharmacol Physiol. 2013; 26(2):101-7. DOI: 10.1159/000346698.Amor K.T., Rashid R.M., Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol online J. 2010; 16(2): 3.Amor K.T., Rashid R.M., Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol online J. 2010; 16(2): 3.Kong J., Li X.J., Gavin D., et al. Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol. 2002; 118(4):631-638. DOI: 10.1046/j.1523-1747.2002.01727.x.Kong J., Li X.J., Gavin D., et al. Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol. 2002; 118(4):631-638. DOI: 10.1046/j.1523-1747.2002.01727.xParikh G., Varadinova M., Suwandhi P., et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. HormMetab Res. 2010; 42(10):754-7. DOI:10.1055/s-0030-1262837.Parikh G., Varadinova M., Suwandhi P., et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. HormMetab Res. 2010; 42(10):754-7. DOI:10.1055/s-0030-1262837.Dankers W., Colin E.M., van Hamburg J.P., et al. Vitamin D Autoimmunity: molecular mechanism and therapeutic potential. Front Immunol. 2016; 7: 697. DOI: 10.3389/fimmu.2016.00697.Dankers W., Colin E.M., van Hamburg J.P., et al. Vitamin D Autoimmunity: molecular mechanism and therapeutic potential. Front Immunol. 2016; 7: 697. DOI: 10.3389/fimmu.2016.00697.Daroach M., Narang T., Saikia U.N., et al. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. Int J Dermatol. 2018; 57(2):217-222. DOI: 10.1111/ijd.13851.Daroach M., Narang T., Saikia U.N., et al. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. Int J Dermatol. 2018; 57(2):217-222. DOI: 10.1111/ijd.13851.Malloy P.J., Feldman D. The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol. 2011; 347(1-2):90-96. DOI: 10.1016/j.mce.2011.05.045.Malloy P.J., Feldman D. The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol. 2011; 347(1-2):90-96. DOI: 10.1016/j.mce.2011.05.045.Gerkowicz A., Chyl-Surdacka K., Krasowska D., et al.The role of vitamin D in non-scarring alopecia. Int J Mol Sci. 2017; 18(12):2653. DOI: 10.3390/ijms18122653.Gerkowicz A., Chyl-Surdacka K., Krasowska D., et al.The role of vitamin D in non-scarring alopecia. Int J Mol Sci. 2017; 18(12):2653. DOI: 10.3390/ijms18122653.Philpott M.P., Sanders D.A., Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. Journal of Investigative Dermatology. 1994; 102(6): 857-61. DOI: 10.1111/1523-1747.ep12382494.Philpott M.P., Sanders D.A., Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. Journal of Investigative Dermatology. 1994; 102(6): 857-61. DOI: 10.1111/1523-1747.ep12382494.Saleh D., Naga S.S.Y., Cook C. Hypertrichosis. StatPearls Publishing LLC., Sept. 12, 2019. PMID: 30521275.Saleh D., Naga S.S.Y., Cook C. Hypertrichosis. StatPearls Publishing LLC., Sept. 12, 2019. PMID: 30521275.Santos Z., Avci P., Hamblin M.R. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov. 2015; 10(3):269–292. DOI: 10.1517/17460441.2015.1009892.Santos Z., Avci P., Hamblin M.R. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov. 2015; 10(3):269–292. DOI: 10.1517/17460441.2015.1009892.Sigalos J.T., Pastuszak A.W., Allison A., et al. Growth hormone secretagogue treatment in hypogonadal men raises serum insulinlike growth factor-1 levels. Am J Mens Health. 2017; 11(6):1752-1757. DOI: 10.1177/1557988317718662.Sigalos J.T., Pastuszak A.W., Allison A., et al. Growth hormone secretagogue treatment in hypogonadal men raises serum insulinlike growth factor-1 levels. Am J Mens Health. 2017; 11(6):1752-1757. DOI: 10.1177/1557988317718662.Kayampilly P.P., Wanamaker B.L., Stewart J.A.,et al. Stimulatory Effect of Insulin on 5α-Reductase Type 1 (SRD5A1) Expression through an Akt-Dependent Pathway in Ovarian Granulosa Cells. Endocrinol. 2010; 151(10):5030–5037. DOI: 10.1210/en.2010-0444.Kayampilly P.P., Wanamaker B.L., Stewart J.A.,et al. Stimulatory Effect of Insulin on 5α-Reductase Type 1 (SRD5A1) Expression through an Akt-Dependent Pathway in Ovarian Granulosa Cells. Endocrinol. 2010; 151(10):5030–5037. DOI: 10.1210/en.2010-0444.Mumcuoglu C., Ekmekci T.R., Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with earlyonset androgenetic alopecia Eur J Dermatol.2011; 21(1):79-82. DOI: 10.1684/ejd.2010.1193.Mumcuoglu C., Ekmekci T.R., Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with earlyonset androgenetic alopecia Eur J Dermatol.2011; 21(1):79-82. DOI: 10.1684/ejd.2010.1193.Starka L., Duskova M., Cermakova I., et al.Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? EndocrRegul. 2005; 39(4):127-131.Starka L., Duskova M., Cermakova I., et al.Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? EndocrRegul. 2005; 39(4):127-131.Cannarella R., Condorelli R.A., Dall’Oglio F., et al. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist? Int J Endocrinol. 2020: 1942126. DOI: 10.1155/2020/1942126.Cannarella R., Condorelli R.A., Dall’Oglio F., et al. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist? Int J Endocrinol. 2020: 1942126. DOI: 10.1155/2020/1942126.Karatas F., Sahin S., Sever A.R, et al. Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview. Springerplus. 2016; 5:585. DOI: 10.1186/s40064-016-2216-3.Karatas F., Sahin S., Sever A.R, et al. Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview. Springerplus. 2016; 5:585. DOI: 10.1186/s40064-016-2216-3.Sawaya М.Е., Price V.H. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997; 109(3):296-300. DOI: 10.1111/1523-1747.ep12335779.Sawaya М.Е., Price V.H. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997; 109(3):296-300. DOI: 10.1111/1523-1747.ep12335779.Lie C., Liew C.F., Oon H.H. Alopecia and the metabolic syndrome. Clin Dermatol. 2018; 36(1):54-61. DOI: 10.1016/j.clindermatol.2017.09.009.Lie C., Liew C.F., Oon H.H. Alopecia and the metabolic syndrome. Clin Dermatol. 2018; 36(1):54-61. DOI: 10.1016/j. clindermatol.2017.09.009.Bakry O.A., Shoeib M.A., Shaffiee M.K., et al Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study. Indian Dermatol Online J. 2014; 5(3):276-81. DOI: 10.4103/2229-5178.137776.Bakry O.A., Shoeib M.A., Shaffiee M.K., et al Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study. Indian Dermatol Online J. 2014; 5(3):276-81. DOI: 10.4103/2229-5178.137776.Cakir E. The association between metabolic syndrome components and hair loss both male and female individuals. Hair Ther Transplant.2013; 3:110. DOI: 10.4172/2167-0951.1000110.Cakir E. The association between metabolic syndrome components and hair loss both male and female individuals. Hair Ther Transplant.2013; 3:110.DOI: 10.4172/2167-0951.1000110.Jingwen Ma Youyu Sheng, Zhengyin Lao, et al. Hyperuricemia is associated with androgenetic alopecia in men: A cross-sectional case-control study J Cosmet Dermatol. 2020;19(11):3122-3126. DOI: 10.1111/jocd.13401.Jingwen Ma Youyu Sheng, Zhengyin Lao, et al. Hyperuricemia is associated with androgenetic alopecia in men: A cross-sectional case-control study J Cosmet Dermatol. 2020;19(11):3122-3126. DOI: 10.1111/jocd.13401.Vinay K., Sawatkar G.U., Dogra S. Hair manifestations of endocrine diseases: A brief review. Indian J Dermatol Venerol Leprol. 2018; 84(5):528-538. DOI: 10.4103/ijdvl.IJDVL_671_17.Vinay K., Sawatkar G.U., Dogra S. Hair manifestations of endocrine diseases: A brief review. Indian J Dermatol Venerol Leprol. 2018; 84(5):528-538. DOI: 10.4103/ijdvl.IJDVL_671_17.Robert S., English Jr. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses. 2018; 111: 73-81. DOI: 10.1016/j.mehy.2017.12.027.Robert S., English Jr. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses. 2018; 111: 73-81. DOI: 10.1016/j.mehy.2017.12.027.Tilwani M.R., Dogra N.K., Dogra D., et al. Androgenetic alopecia as a maker of metabolic syndrome in male patients of androgenetic alopecia: a hospital-based case control study. Int J Res Med Sci. 2017; 5(2):601-606. DOI: 10.18203/2320-6012.ijrms20170159.Tilwani M.R., Dogra N.K., Dogra D., et al. Androgenetic alopecia as a maker of metabolic syndrome in male patients of androgenetic alopecia: a hospital-based case control study. Int J Res Med Sci. 2017; 5(2):601-606. DOI: 10.18203/2320-6012.ijrms20170159.Dharam Kumar K.C., Yadalla Hari Kishan Kumar, Vivekananda Neladimmanahally. Association of Androgenetic Alopecia with Metabolic Syndrome: A Case–control Study on 100 Patients in a Tertiary Care Hospital in South India. Indian J Endocrinol Metab. 2018; 22(2):196-199. DOI:10.4103/ijem.IJEM_650_17.Dharam Kumar K.C., Yadalla Hari Kishan Kumar, Vivekananda Neladimmanahally. Association of Androgenetic Alopecia with Metabolic Syndrome: A Case–control Study on 100 Patients in a Tertiary Care Hospital in South India. Indian J Endocrinol Metab. 2018; 22(2):196-199. DOI:10.4103/ijem.IJEM_650_17.Caihong Xin, Xin Sun, Li Lu, et al. Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis. Dermatology.2020;236(3):251-254. DOI: 10.1159/000502025.Caihong Xin, Xin Sun, Li Lu, et al. Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis. Dermatology.2020;236(3):251-254. DOI: 10.1159/000502025.Bhat Y.J, Saquib N., Latif I., et al. Female Pattern Hair Loss— An Update. IndianDermatol. OnlineJ. 2020; 11(4):493-501. DOI: 10.4103/idoj.IDOJ_334_19.Bhat Y.J, Saquib N., Latif I., et al. Female Pattern Hair Loss— An Update. IndianDermatol. OnlineJ. 2020; 11(4):493-501. DOI: 10.4103/idoj.IDOJ_334_19.

The authors declare that there are no conflicts of interest present.